← All stocks

RedHill Biopharma Ltd.

RDHL Scheduled selling only
CIK 0001553846 #5494 in the set updated 20 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.99K
$0.00 on a plan · $2.99K straight out of an exercise
Sold at will
$0.00
0 of 2 sales
Net
−$2.99K
$0.00 against sales at will

By person

1 insider · 2 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Raday Gilead
Chief Operating Officer
$2.99K (2) scheduled
−$2.99K
218,780,000
$21.88K
−12.0%

No percentages here. This company's share count has moved by a factor of 3.9 over the window, from 12,899,831,000 to 50,923,261,000 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Raday Gilead
10 Jul 2026
Chief Operating Officer
Sold after exercise
14,130,000
$0.00
$1.41K
Raday Gilead
6 Apr 2026
Chief Operating Officer
Sold after exercise
15,740,000
$0.00
$1.57K

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 22 Apr 2026